Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
396.17
0.00 (0.00%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $10.31 billion as of August 26, 2026. Its market cap has increased by 28.77% in one year.
Market Cap
10.31B
Enterprise Value
10.06B
1-Year Change
28.77%
Ranking
Category
Stock Price
$396.17
ChartMarket Cap Chart
Since August 27, 2021, Bio-Rad Laboratories's market cap has decreased from $23.62B to $10.31B, a decrease of -56.36%. That is a compound annual growth rate of -15.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 10.31B | 26.21% |
| Dec 31, 2025 | 8.17B | -11.01% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | -4.27% |
| Aug 27, 2021 | 23.62B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| STERIS | 23.10B |
| Zimmer Biomet Holdings | 19.29B |
| Penumbra | 12.77B |
| Smith & Nephew | 12.26B |
| Globus Medical | 11.44B |
| Glaukos | 10.86B |
| Insulet | 10.15B |
| Bio-Rad Laboratories | 10.04B |